Main outcome measures All cause mortality and cause specific mortality with the main focus on cancer and cardiovascular disease.
主要的评价结果指标:全死因死亡率以及恶性肿瘤、心血管疾病死亡专率。
Subgroup analyses indicated that prostate cancer-specific mortality was not affected by the age at which participants were screened.
次群组分析指出,摄护腺癌死亡率不受筛检受试者的年龄影响。
Only one study (ERSPC) reported a 21% significant reduction of prostate cancer-specific mortality in a pre-specified subgroup of men aged 55 to 69 years.
只有一个研究(ERSPC)记录了在预先指定、55至69岁男性的次群组中,摄护腺癌死亡率有21%的显著降低。
The cause-specific mortality of the acute infectious diseases, tuberculosis, neonatal diseases, diseases of respiratory and digestive systems have dropped obviously.
急性传染病、结核病、新生儿疾病、呼吸系疾病与消化系疾病的死亡率明显下降。
Methods Mortality rate, disease-specific mortality rate, valued years of potential life lost(VYPLL) and years of life lost(YLLs) were used to analyze causes of death.
方法用死亡率、死因别死亡率、潜在价值损失年数及死亡所致生命损失年等指标,分析居民死因。
The main associations of body-mass index (BMI) with overall and cause-specific mortality can best be assessed by long-term prospective follow-up of large Numbers of people.
获得体重指数(BMI)与整体和病因特异性死亡率之间的主要联系的最好的方法,就是对大数量人群进行的长期前瞻性随访。
To determine whether screening for prostate cancer reduces prostate cancer-specific mortality or all-cause mortality and to assess its impact on quality of life and adverse events.
判断摄护腺癌筛检是否能降低摄护腺癌死亡率或总死亡率,并评估它对于生活品质及不良事件的影响。
This paper recommends the use of the geometric mean of the age-specific mortality rates as a summary index of mortality. This index is intuitively simple, easy to calculate, and it ne...
本文以年龄别死亡率几何均数作为年龄别死亡率的一个概括指标,优点是直观简单、易计算、不需要标准人口、不同人口可直接比较,并可反映年龄别死亡率的指数类型。
This paper recommends the use of the geometric mean of the age-specific mortality rates as a summary index of mortality. This index is intuitively simple, easy to calculate, and it ne...
本文以年龄别死亡率几何均数作为年龄别死亡率的一个概括指标,优点是直观简单、易计算、不需要标准人口、不同人口可直接比较,并可反映年龄别死亡率的指数类型。
应用推荐